Yugen Medtech Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2020

Location

Tianjin China

Primary Industry

Pharmaceuticals

About

Established in 2020 and based in Tianjin, China, Yugen Medtech is a contract development and manufacturing organization that specializes in innovative drug potency research, pre-clinical and clinical stage systematic evaluation, and registration services, which is a subsidiary of Kailaiying Pharmaceutical Group. It has set up a laboratory in Shanghai. In December 2020, Yugen Medtech raised CNY 22.50 million in strategic investment from new investor Trinity Innovation Fund. The company is committed to providing technical services covering pharmacokinetics, pharmacology, and toxicology for new drug research and development institutions and pharmaceutical companies. The business includes small molecule analysis and pharmacokinetic research, biopharmaceutical analysis and pharmacokinetic research, and other services.

Current Investors

Trinity Innovation Fund

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development

Website

www.yugenmed.com

Verticals

HealthTech

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.